| #35 |
Prem Krish |
Energy Recovery |
4 |
| #35 |
Taeho Kgil |
Visa |
4 |
| #35 |
Elhum Amjadi |
Microsoft |
4 |
| #35 |
Wei-Ching Liang |
Genentech |
4 |
| #35 |
Kiushan Pirzadeh |
Visa |
4 |
| #35 |
Simon Hurry |
Visa |
4 |
| #57 |
Theodore Harris |
Visa |
3 |
| #57 |
Nicholas R. Vitale |
Apnicure |
3 |
| #57 |
Craig O'Connell |
Visa |
3 |
| #57 |
Jason Liu |
Thermo Fisher |
3 |
| #57 |
Mark A. Collins |
View |
3 |
| #57 |
Rajkumar Sen |
Oracle |
3 |
| #57 |
Richard Mark Ramsden |
Walmart Apollo |
3 |
| #57 |
Suresh Srinivasan |
Intel |
3 |
| #57 |
James Dimmick |
Visa |
3 |
| #57 |
Randall L. Halcomb |
Gilead Sciences |
3 |
| #57 |
Paul Durdik |
Ultrahaptics Ip Two Limited |
3 |
| #57 |
Lawrence Chang |
Google |
3 |
| #57 |
Boyan Zhang |
Beijing Mabworks Biotech Co. |
3 |
| #57 |
Jeremy Lackey |
Quantum-Si Incorporated |
3 |
| #57 |
John Yeh |
Artiva |
3 |
| #57 |
Bipul Sinha |
Oracle |
3 |
| #57 |
Thomas G. Salter |
Apple |
3 |
| #57 |
Krishnakumar Ramamoorthy |
Caterpillar |
3 |
| #57 |
Rao Kolluri |
Rigel Pharmaceuticals |
3 |
| #57 |
Ramesh Baliga |
Igm Biosciences |
3 |
| #57 |
Daniel H. Byun |
Gilead Sciences |
3 |
| #57 |
Wenjin Yang |
Stanford University |
3 |
| #57 |
Yan Wang |
Bio-Rad Laboratories |
3 |
| #57 |
Vikram Pavate |
Apple |
3 |
| #57 |
Michael C. DeLaet |
Kabam, |
3 |
| #57 |
Yuandi Jin |
Oracle |
3 |
| #57 |
Sachin Kulkarni |
Oracle |
3 |
| #57 |
Robert D. Hopkins |
Oracle |
3 |
| #57 |
Harpinder Singh Madan |
Slice Technologies |
3 |
| #57 |
Vikrant Akavaram |
IBM |
3 |
| #57 |
Carina E. Cannizzaro |
Gilead Sciences |
3 |
| #57 |
Lei Ling |
Ngm Biopharmaceuticals |
3 |
| #57 |
Gursev Singh Kalra |
Salesforce |
3 |
| #57 |
Kenneth Huang Young |
Konica Minolta Laboratory U.S.A. |
3 |
| #57 |
Igor Borovikov |
Electronic Arts |
3 |
| #57 |
Horia Simionescu |
Avago Technologies General Ip (Singapore) Pte. |
3 |
| #57 |
Wanmin Wu |
Ricoh Company |
3 |
| #57 |
Hui-Ping Chen |
Young Optics |
3 |
| #95 |
Jeff Tillack |
Credence Medsystems |
2 |
| #95 |
Edward Doerffler |
Gilead Sciences |
2 |
| #95 |
Sunil P. Chakkappen |
Oracle |
2 |
| #95 |
Venkat R. Thalladi |
Theravance Biopharma R&D Ip |
2 |
| #95 |
Zhongxu Ren |
Nektar Therapeutics |
2 |
| #95 |
Fei Huang |
Geron |
2 |